Categories: SCIENCE

MDMA was hyped as a promising treatment for PTSD – what went wrong?


MDMA has long been used recreationally but it has faced obstacles getting approved for medical therapies

Shutterstock / Couperfield

“The future is psychedelic,” declared Rick Doblin, founder of Lykos Therapeutics, at a conference on psychedelic drugs last year. Several studies, many of them funded by Lykos, had provided tantalising signs that pairing MDMA with talk therapy could dramatically reduce symptoms of post-traumatic stress disorder (PTSD). As a result, Doblin was one of many advocates touting the drug as key to revolutionising mental healthcare.

But just a year later,…



Source link

fromermedia@gmail.com

Share
Published by
fromermedia@gmail.com

Recent Posts

why scientists are joining the rush to Bluesky

Bluesky has been growing rapidly since 2023.Credit: Matteo Della Torre/NurPhoto/ShutterstockResearchers are flocking to the social-media…

4 hours ago

Bacteria found on a space rock turn out to be Earth-grown

Be wary of claims of alien life in samples from space, say researchers who found…

6 hours ago

Chimps tickle and wrestle in play to pave the way for teamwork

Adult chimpanzees (Pan troglodytes) play together to promote cooperation and ease tension, according to field…

6 hours ago

Next-generation snakebite therapies could reduce death toll

A spitting cobra can deliver venom either through a bite or by ejecting it from…

6 hours ago

Swallowable injections: the octopus-inspired pill that delivers drugs with a jet

Nature, Published online: 20 November 2024; doi:10.1038/d41586-024-03824-1Can jets of drugs from pressurized capsules replace needles?…

9 hours ago

Students and grandmothers step up where mental health-care is in short supply

Hello Nature readers, would you like to get this Briefing in your inbox free every…

10 hours ago